HALIFAX, NS / ACCESSWIRE / January 9, 2025 / Today, MedMira Inc. (MedMira) (TSXV:MIR) announced that its received investigational testing authorization (ITA) from Health Canada to begin clinical ...
Novo Nordisk A/S and Valo Health, Inc. today announced they have entered into an expanded agreement to discover and develop ...
Black Book Research, the trusted independent evaluator of healthcare IT solutions, has named ClinicMind the top-ranked vendor for Chiropractic Electronic Health Records (EHR) and Practice Management ...
VANCOUVER, BC / ACCESSWIRE / January 9, 2025 / Onco-Innovations Limited (CSE:ONCO)(Frankfurt:W1H, WKN: A3EKSZ) ("Onco" or the "Company") is pleased to provide information on its exclusively-licensed ...
SAN CARLOS, CA and FORT WORTH, TX / ACCESSWIRE / January 9, 2025 / CAGE Bio, Inc., a clinical-stage biotechnology company advancing innovative therapies for high incidence immuno-dermatological ...
There are approximately 385,000 needlestick and sharps-related injuries among healthcare workers each year in the U.S., based on CDC reports. ORLANDO, FLORIDA / ACCESSWIRE / January 9, 2025 / With the ...
The Certification Joins Quest's 4 Existing ISO Registrations to Form the Industry's Most Complete Quality Management System IRVINE, CALIFORNIA / ACCESSWIRE / January 9, 2025 / Quest International, the ...
Tenon Medical(R) to Host Meetings During the 2025 J.P. Morgan Healthcare Conference in San Francisco
LOS GATOS, CA / ACCESSWIRE / January 9, 2025 / Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon" or the "Company"), a company transforming care for patients suffering from certain Sacroiliac Joint (SIJ) ...
Three customers take delivery at year endVANCOUVER, BC / ACCESSWIRE / January 9, 2025 / UniDoc Health Corp. (CSE:UDOC)(FRA:L7T)(OTCQB:UDOCF) ("UniDoc," or the "Company"), an innovator in the eHealth ...
Exclusive Distributor to Drive International Growth in Chile, Argentina, Peru and Colombia LOS ANGELES, CA / ACCESSWIRE / January 9, 2025 / Med-X, Inc., a leading innovator of all-natural green scene ...
Astraveus SAS (“Astraveus” or the “Company”), the Benchtop Cell Factory company, today announces the first ever successful end-to-end production of CAR-T cells within a microfluidic benchtop system.
Results from the investigational, randomized, open-label IRAKLIA phase 3 study demonstrated that Sarclisa administered at a fixed dose subcutaneously (SC) via an on-body delivery system (OBDS) in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback